GDP Responsible Person in Germany: the § 52a AMG role behind every wholesale authorisation

Every pack on a German pharmacy shelf has travelled a distribution route, and at the end of that route sits an authorisation under § 52a of the German Medicines Act. That authorisation hangs on one name. The verantwortliche Person, in English simply the Responsible Person or RP for GDP, may be the quietest of Germany's statutory pharma roles. It rarely appears as a job title of its own, and candidates almost never name it as a career target.

That is a missed opportunity. In 16 years of pharma recruitment I have seen few roles that move people from an operational position into named legal responsibility this quickly, and fewer still that are genuinely open to people without a classic pharma CV. Here is why.

What the Responsible Person actually owns

German law says little about the duties; the EU GDP guidelines say a great deal. Chapter 2.2 sets out what this person answers for: implementing and maintaining the quality management system, managing the authorised activities and the accuracy and quality of records, organising initial and continuous training, coordinating and promptly executing recall operations, dealing with customer complaints, approving suppliers and customers, approving subcontracted activities that touch GDP, carrying out self-inspections at regular intervals with corrective measures, keeping records of any delegated duties, and deciding the final disposition of returned, rejected, recalled or falsified products.

One sentence in the guidelines carries the whole role: duties may be delegated, responsibilities may not. When a pallet sat at 30 degrees in a truck, when a customer suddenly orders volumes that do not match their pharmacy size, when a class 1 recall is running, this person decides. And they are expected to be continuously contactable.

The legal basis in brief: § 52a AMG

Anyone conducting wholesale distribution of medicinal products in Germany needs an authorisation. The application requires four things: naming the specific site, the activities and the products; evidence of suitable premises, installations and equipment for storage and distribution; naming a responsible person who holds the expertise required to carry out the activity; and a written undertaking to comply with the rules governing proper wholesale operation.

The authorisation may be refused where those conditions are missing, or where facts suggest that the applicant or the responsible person lacks the required reliability. Every change to the stated particulars, including a change of responsible person, is notified to the competent authority. No named person means no authorisation, which is exactly why this seat is never vacant for long and why the interim market for it is active.

The expertise question, and why it opens the door

§ 52a does not define the expertise. No degree course, no minimum years, no cross-reference to § 15 AMG, which sets out precisely what is required of the Qualified Person in manufacturing. For career planning, that is the single most useful fact in this article.

How far the term reaches was settled by the German Federal Administrative Court on 5 November 2020 (3 C 7.19 and 3 C 9.19). The holding: the responsible person cannot be required to have pharmaceutical knowledge equivalent to that taught in a pharmaceutical vocational training. Expertise may be gained through practical experience, in particular through work under the guidance and supervision of a responsible person. Product-specific knowledge may be required insofar as the particular medicines demand it, for instance cold-chain or otherwise sensitive goods.

Alongside that sits an expectation rather than an obligation: the EU GDP guidelines state that a degree in pharmacy is desirable, and that the person should have appropriate competence and experience as well as knowledge of and training in GDP. Between those two poles the German state authorities assess each case. A pharmacist is rarely questioned. A logistics manager with ten years of medicinal-product experience, documented GDP training and a supervised handover under a named RP now has a solid argument too.

The entry routes that work in practice

Four routes recur. The first comes out of community pharmacy: pharmacists and pharmaceutical technicians move into wholesale, often for predictable hours, and bring product knowledge from day one. The second comes from quality assurance: if you know deviations, CAPA and self-inspections from the GMP world, GDP reads familiar, because the systems logic is the same.

The third route climbs from logistics and supply chain, and it is the most underrated. Anyone who has owned temperature control, warehouse qualification and transport validation is already working inside the core of GDP. What is usually missing is documented GDP training and supervised time. The fourth is internal promotion at a wholesaler through the deputy seat. As with Germany's other named roles, the deputy period is the evidence that matters later. Take it when it is offered.

Who hires across DACH

The market is wider than the word wholesale suggests. Full-line wholesalers supply pharmacies nationally from large distribution centres. Specialist wholesalers handle cold chain, controlled drugs, high-value products or cell and gene therapies. Pharma logistics and contract logistics providers hold their own wholesale authorisations on behalf of clients. Manufacturers run a wholesale authorisation alongside their manufacturing licence. Parallel importers, hospital suppliers and clinical trial depots complete the picture.

Each of those operations needs at least one named person, and many need several sites covered. For the neighbouring functions and who is hiring across the region, see the overview of supply chain jobs in pharma. Austria and Switzerland run their own national requirements for the responsible person in medicinal product distribution, so check the target country separately if you are planning across DACH.

What a CV has to evidence

From a recruiter's chair, proximity to the rulebook decides. A strong profile names GDP experience with substance: quality system processes you owned, supplier and customer qualification with numbers, recalls you led or supported, self-inspections and your role in them, temperature monitoring and deviation handling, authority inspections with outcomes, plus product types and special requirements such as cold chain or controlled substances. If you have been named, or served as deputy, write it with dates. Those same terms are what applicant tracking systems filter on; how to handle that is covered in the guide on the ATS in pharma.

A note on salary

No band here. Compensation depends on whether the appointment sits with a site or quality leadership role, the size and sensitivity of the product range, whether the employer is a full-line wholesaler, a specialist or a logistics provider, and whether the role is held in-house or as a mandate. A single figure without those variables would mislead you. The mechanism is reliable: the appointment lifts the level well above a purely operational warehouse or quality role, and it belongs in every salary conversation. How to build that argument is on the pharma salary negotiation page.

Frequently asked questions

Do you need a pharmacy degree to be the Responsible Person in Germany?

No. On 5 November 2020 the German Federal Administrative Court (3 C 7.19 and 3 C 9.19) held that pharmaceutical knowledge equivalent to a pharmacy training cannot be required. Expertise may be acquired through practical experience, in particular by working under the guidance and supervision of a responsible person. Product-specific knowledge can be demanded where the particular medicines require it. The EU GDP guidelines call a degree in pharmacy desirable, not mandatory.

What does the Responsible Person do day to day?

Chapter 2.2 of the EU GDP guidelines lists the duties: implementing and maintaining the quality management system, managing authorised activities and the accuracy of records, initial and continuous training, coordinating recalls, handling complaints, approving suppliers and customers, approving subcontracted GDP activities, running self-inspections with corrective actions, keeping records of delegated duties, and deciding the final disposition of returned, rejected, recalled or falsified products. Duties may be delegated, responsibilities may not.

How does this differ from the Qualified Person under § 14 AMG?

The Qualified Person owns manufacturing and certifies batches before release, under the detailed requirements of § 15 AMG. The § 52a responsible person owns the distribution route afterwards: storage, transport, suppliers and customers, recalls. Each role sits under its own authorisation, and the expertise requirements are regulated with very different levels of detail.

Can the role be held externally or for several companies?

External mandates are common at smaller wholesalers, logistics providers and manufacturers holding their own wholesale authorisation. The EU GDP guidelines require the responsible person to be continuously contactable, which in practice limits how many mandates one person can carry. The competent state authority assesses each appointment and must be notified of every change.

Sources

§ 52a AMG, wholesale distribution of medicinal products (gesetze-im-internet.de, German)
EU Guidelines on Good Distribution Practice (2013/C 343/01), chapter 2.2 (EUR-Lex)
Federal Administrative Court, judgment of 5 November 2020, 3 C 7.19
§ 14 AMG, manufacturing authorisation (gesetze-im-internet.de, German)

© 28 July 2026 Andreas Schulz. All rights reserved. This article is career guidance, not legal advice; the statutory text and the competent authority's assessment prevail.